Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
- Status
- COMPLETED
- Phase
- NA
A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients
- Status
- UNKNOWN
- Phase
- N/A
UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Imaging Young Myeloma (IMAgerie JEune Myélome)
- Status
- COMPLETED
- Phase
- PHASE3
Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2